The insurers are already looking at the price tag

When the Board pitches the five-year psychology degree to prospective students, it sells it as an accelerated pathway: finish faster, get registered sooner, and walk straight into a career.

If you want to know what the market actually thinks, look at the submission from Medibank.

Private health insurers don’t trade in academic sentiment or regulatory spin. They operate on actuarial tables, risk distribution and benefit outlays.

In its consultation feedback, Medibank cut through the promotional language to ask the fundamental economic questions: what does this mean for clinical safety, and how will funding and rebate models differentiate between different qualification levels?

Translate that out of insurer-speak and into plain English.

My read is that Medibank isn’t asking out of academic curiosity. It is asking because private payers don’t pay full rates for downgraded qualification benchmarks.

By pushing general registration down from a postgraduate standard (AQF 9) to an undergraduate Honours level (AQF 8), the Board is creating a qualification that major payers are already eyeing for tiered rebates.

What “differentiated funding” means in practice

In the real world, it leads to three predictable outcomes:

• Tiered private rebates. Insurers set lower benefit schedules for AQF 8 practitioners than for postgraduate-trained psychologists.
• Depressed starting wages. Award negotiations and corporate clinic models use the AQF 8 classification to anchor lower baseline salaries.
• Higher gap fees for patients. If insurers pay lower rebates for five-year graduates, the shortfall doesn’t vanish. It gets pushed directly onto the consumer.

The Board is asking students to absorb hundreds of unpaid placement hours and take on significant debt on the promise of an equitable professional career. Meanwhile, the largest healthcare funders in the country are already foreshadowing a discount on the value of that qualification before the first student has even graduated.